All Perspectives

Latin America Desk Head, Hunter T. Carter recently co-authored, for the fourth year, Challenging and Enforcing Arbitration Awards: Colombia, a chapter in Global Arbitration Review’s Challenging and Enforcing Arbitration Awards guide.

Longevity & Healthspan Industry Co-Leader Gayland Hethcoat was quoted in a segment airing on Germany’s national public radio about brain-computer interfaces (BCIs), an emerging technology for treating diseases and conditions with neurological causes.

Longevity & Healthspan Industry Co-Leader Abha Kundi, a former US Food and Drug Association (FDA) regulator, was quoted on the complexities surrounding an FDA advisory committee recommending six peptides to be added to the Section 503A Bulks List.

On August 6, the US Food and Drug Administration (FDA) announced it is extending an existing Drug Supply Chain Security Act (DSCSA) exemption for small dispensers until November 27, 2027, as the FDA begins its small dispenser assessment.

At the midpoint of 2026, the agriculture industry is navigating a complex and ever-changing legal landscape shaped by the evolution of artificial intelligence (AI), trade and capital-market uncertainty, regulatory reform, and other policy issues.

On July 22, the US Securities and Exchange Commission (SEC) approved Nasdaq’s proposed rule requiring all Nasdaq-listed companies to maintain a minimum Market Value of Listed Securities (MVLS) of at least $5 million. Companies falling below this threshold for 30 consecutive business days would face immediate suspension and delisting.

Fashion trademark disputes often turn on a deceptively simple question: when does a design feature stop being decoration and start functioning as a brand identifier?

A lawsuit against sneaker brand On asks how much national pride a label can sell before it crosses the line into deception.

Health Care Practice Co-Leader Douglas Grimm was a featured guest on Competition Policy International, a PYMNTS company, to discuss how deregulating artificial intelligence (AI) for use in health care doesn’t necessarily remove barriers to the industry’s adoption.

Longevity & Healthspan Industry Co-Leader Abha Kundi, a former US Food and Drug Association (FDA) regulatory counsel, was quoted on a recent vote from an FDA advisory committee that recommended six (out of seven) peptide substances for lawful compounding.

Counsel Judah Prero was quoted on the Minnesota Chamber of Commerce’s request to state regulators to delay reporting requirements for products containing per- and polyfluoroalkyl substances (PFAS).

ArentFox Schiff announced today the addition of an elite trademark and brands team anchored by highly ranked brand and copyright attorney Jason Garcia and globally recognized trademark attorney Katherine (Katy) M. Basile.

On June 17, the Council of the European Union (EU) and the European Parliament formally adopted the long-debated regulation for plants developed using certain new genomic techniques (NGTs).

Can your association board and senior leadership team answer these seemingly straightforward questions: “Where are our most important contracts, and is someone tracking what they require?” For many associations, the honest answer is that contract management happens in pieces across departments, in response to questions, and without dedicated trade association legal counsel weighing in until a problem surfaces.

Family Offices Industry Co-Leader Kevin Matz was quoted on the value of trust protectors in both revocable and irrevocable trust plans and can be useful even for responsible family members.

Earlier this year we flagged New York’s “synthetic performer” disclosure law, N.Y. General Business Law § 396-b, the Synthetic Performer Law, as one to watch. The watch is over.

On July 14, the US Food and Drug Administration (FDA) announced final guidance regarding clinical investigations of psychedelic drugs.

Prop 65 Counsel: What To Know

Headlines that Matter for Companies and Executives in Regulated Industries

A recent California Superior Court decision against Kars4Kids, the charity known for its memorable advertising jingle, demonstrates the significant risks that charities can face if their solicitations are found to be misleading.

The Pharmacy Compounding Advisory Committee (PCAC) is a 14-member US Food and Drug Administration (FDA) advisory panel of pharmacists, physicians, and other experts. It reviews the scientific and safety record for bulk drug substances nominated for compounding and votes on non-binding recommendations to the FDA.

The US Department of Justice (DOJ) is increasingly using the False Claims Act (FCA) to pursue customs fraud, tariff evasion, and duty underpayments, resulting in significant settlements and expanded enforcement activity.

On June 26, Illinois Governor JB Pritzker signed House Bill 4517 into law, amending the Illinois Authorized Electronic Monitoring in Long-Term Care Facilities Act.

On July 13, the US Food and Drug Administration (FDA) proposed a new rule that would fundamentally change how certain drug manufacturers register their facilities and list their products with the agency.

California family offices with clients at or near the $1 billion net worth threshold should be monitoring Proposition 40, the 2026 Billionaire Tax Act, which has qualified for the November 3 ballot and could impose a one-time tax of up to 5% on the net worth of certain California residents if approved by voters.